Ibudilast awarded patent for treating progressive MS, Europe

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Ibudilast awarded patent for treating progressive MS, Europe

Postby MSUK » Fri Oct 26, 2012 3:12 am


Biopharmaceutical company MediciNova Inc reported on Thursday the receipt of a Notice of Allowance from the European Patent Office for an application covering the use of ibudilast for progressive forms of multiple sclerosis (MS), a chronic disease in which disability progresses over time.

According to the company, ibudilast (MN-166) is its drug development candidate for certain neurological conditions, including primary progressive or secondary progressive MS, drug addiction and pain.

The company's patent maturing from this allowed patent application is expected to expire no earlier than early 2029 and covers a method of treating progressive MS.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1311
MS-UK - http://www.ms-uk.org/
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to General Discussion


  • Related topics
    Last post

Who is online

Users browsing this forum: Bing [Bot], ElliotB

Contact us | Terms of Service